Insiders · RXRX

Blake Borgeson

Director at Recursion Pharmaceuticals, Inc. (RXRX)

Blake Borgeson has filed 83 insider reports with the SEC since April 2021, as director at Recursion Pharmaceuticals, Inc. (RXRX). In the last 12 months Blake Borgeson sold $4.25M of stock on the open market. In the latest filing, on November 4, 2026, Blake Borgeson sold 40,000 shares of Recursion Pharmaceuticals, Inc. (RXRX) for $155K at an average of $3.88.

Filings
83
Companies
1
Bought on market
None
Sold on market
$10.5M

Companies where Blake Borgeson is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Recursion Pharmaceuticals, Inc. logo
RXRX
Recursion Pharmaceuticals, Inc.
Director6,068,287$10.5M$2.45Nov 4, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Blake Borgeson with

Other insiders at the same companies

Questions about Blake Borgeson

What is Blake Borgeson's role at Recursion Pharmaceuticals, Inc.?
Blake Borgeson reports to the SEC as director at Recursion Pharmaceuticals, Inc. (RXRX), according to the latest filing on November 4, 2026.
How many shares does Blake Borgeson own?
After the latest filing that states it, Blake Borgeson directly owned 6,068,287 shares of Recursion Pharmaceuticals, Inc. (RXRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Blake Borgeson bought or sold stock recently?
The most recent open-market sale was on November 3, 2026: sold 40,000 shares of Recursion Pharmaceuticals, Inc. (RXRX) for $155K at an average of $3.88.
How do I get alerts when Blake Borgeson files?
Follow Blake Borgeson on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Blake Borgeson filed 2 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Blake Borgeson (SEC CIK 0001856094). Totals count each trade once, skipping amendments whose original is on file, from Apr 19, 2021 on. View on SEC EDGAR · Get this as JSON